Table 2 Infant outcomes
All infants(n = 40)Survivors(n = 28)Labour ward deaths (n = 2)Neonatal unit deaths(n = 10)
1 min Apgar, median (interquartile range)5 (2, 6)6 (4, 7)1 (1, 1)2 (1, 3)
5 min Apgar, median (interquartile range)8 (6, 8)8 (7, 8)1 (0, 1)6 (4, 4)
Cord pH, median (interquartile range)7.27 (7.23, 7.33) n = 107.22 (7.21, 7.29) n = 5
Pneumothorax, n (%)15 (35)7 (25)08 (80)
Intubated and ventilated, n (%)31 (78)19 (68)2 (100)10 (100)
Nasal CPAP and never intubated, n (%)5 (13)5 (7)0 (0)
Surfactant administered, n (% of those ventilated)25 (81)17 (89)8 (80)
Chronic lung disease, n (%)14 (35)12 (43)2 (100)*
Total duration (h) CPAP, median (interquartile range)28 (0, 447)112 (10, 522)0 (0, 0)
HFOV
    Number of infants, n (% ventilated infants)17 (55)8 (29)9 (90)
    Total duration (h), mean (SD)27 (0, 89)378 (10, 71)9 (2, 24)
Postnatal steroids, n (%)3 (8)1 (4)2 (20)
Retinopathy of prematurity stage 3110
  • *Only two infants survived beyond 36 weeks’ corrected age.

  • CPAP, continuous positive airway pressure; HFOV, high-frequency oscillatory ventilation.